爱游戏平台注册登录
Breast Cancer Cell Lines

Application Note

Measuring PD-L1 Expression in Breast Cancer Cell Lines with AlphaLISA

Breast Cancer Cell Lines

Introduction

Too many candidates, too little time. The lack of robust, rapid, high-throughput assays to identify and qualify potential therapeutic targets in areas such as cancer research continues to cost valuable time. What if you could increase assay throughput without compromising sensitivity, obtain more data points from each sample and eliminate tedious wash steps? Find out how AlphaLISA® assay technology, combined with the EnVision® multimode plate reader, provides a fast, powerful, homogeneous platform for screening potential inhibitors of PD-L1 (a protein associated with breast cancer tumor cells) expression in human cells.

Baidu
map